Is hExo a good investment?
Learn more HEXO (TSX:HEXO ) ( NASDAQ:HEXO) is one of the largest licensed cannabis companies in Canada. It’s okay to be bullish on the Canadian cannabis industry, but HEXO stock is not for cautious investors. The promise of wealth in the marijuana market was fully realized just a few years ago.
Can you right the ship at hExo Corp (hExo)?
Efforts to right the ship at Hexo Corp. have yet to produce any significant or beneficial results Down 75% over the past six months and falling, troubled Canadian cannabis stock Hexo Corp. (NASDAQ: HEXO) stock is quickly going up in smoke.
Why is hExo’s stock tanking?
The Canadian cannabis producer is struggling to remain a going concern and its stock is tanking. Down 99% from its all-time high, cannabis producer Hexo ( HEXO) is struggling to maintain its listing on the Nasdaq exchange The company reported a quarterly loss of nearly $700 million at the end of March, shaking investor confidence
What happened to hExo stock in 2021?
Between June 2021 and to date, shares in HEXO stock have fallen like a stone. This really hit a new level at the end of August, when an after-hours announcement released to shareholders stated it would be issuing new shares in the “…context of the market.” The company agreed to purchase 47,457,628 units at US$2.95 each, raising US$140 million.
Should I sell my HEXO stock?
7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 1 sell rating and 6 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HEXO stock.
Is HEXO stock a good investment?
The consensus EPS estimate for the current year has increased 32.9% over the last 30 days. This means that the Wall Street analysts covering HEXO are majorly in agreement about the company's potential to report better earnings than what they predicted earlier.
Is HEXO stock a good buy 2022?
On average, analysts forecast that HEXO's EPS will be -$1.93 for 2022, with the lowest EPS forecast at -$2.04, and the highest EPS forecast at -$1.71. On average, analysts forecast that HEXO's EPS will be -$0.09 for 2023, with the lowest EPS forecast at -$0.19, and the highest EPS forecast at -$0.03.
Does HEXO have a future?
The 7 analysts offering 12-month price forecasts for Hexo Corp have a median target of 0.19, with a high estimate of 0.39 and a low estimate of 0.12. The median estimate represents a +2.76% increase from the last price of 0.19.
Will HEXO go out of business?
The answer is a resounding “no.” Hexo Corp. is a failing cannabis company, one that is struggling to remain a going concern and avoid both bankruptcy and delisting from the Nasdaq exchange. Massive losses, poor sales, declining market share, and an activist shareholder are hurting the cannabis producer.
How high does HEXO go?
Stock Price Forecast The 8 analysts offering 12-month price forecasts for Hexo Corp have a median target of 0.21, with a high estimate of 0.42 and a low estimate of 0.12. The median estimate represents a +10.40% increase from the last price of 0.19.
Will Tilray buy HEXO?
Tilray Brands Inc. TLRY, -10.57% rose 1.3% in premarket trades on Tuesday after the cannabis company said it crafted more favorable terms in its deal to acquire Hexo Corp. HEXO, -5.00% .
Is HEXO a buy Zacks?
The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Does Tilray own HEXO?
The previously announced deal will see Tilray and Hexo work together through a strategic agreement, where Tilray will serve as third-party manufacturer for Hexo, the companies will share savings on a 50:50 basis and Hexo will pay Tilray an annual fee of $18 million for advisory services.
Is HEXO a good stock to buy 2021?
HEXO is a market leader in the Canadian cannabis market and is expected to increase sales by 84% to $227.66 million in fiscal 2022 and by 31% to $298 million in fiscal 2023. Bay Street also expects its loss per share to narrow from $0.89 in 2021 to $0.22 in 2023.
Is 2022 a Bull or a Bear?
The bear market of 2022 has been marked, first, by an adjustment to higher interest rates — and therefore lower price-earnings multiples — and, second, by the growing expectation that a possible recession will cut into companies' profits.
What to expect from HEXO next earnings?
Earnings Summary Look out for HEXO's next earnings release expected on November 04, 2022. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 53.33%.
Should I buy or sell HEXO stock right now?
6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 1 sell rating...
What is HEXO's stock price forecast for 2022?
6 brokers have issued 12-month target prices for HEXO's stock. Their forecasts range from C$0.64 to C$7.50. On average, they expect HEXO's share pr...
How has HEXO's stock price performed in 2022?
HEXO's stock was trading at C$0.88 at the beginning of the year. Since then, HEXO stock has decreased by 63.1% and is now trading at C$0.33. View...
When is HEXO's next earnings date?
HEXO is scheduled to release its next quarterly earnings announcement on Monday, June 13th 2022. View our earnings forecast for HEXO .
Who are HEXO's key executives?
HEXO's management team includes the following people: Mr. Roch Vaillancourt , Gen. Counsel Mr. Charlie Bowman , Acting Pres & CEO Mr. Julius Iva...
Who are some of HEXO's key competitors?
Some companies that are related to HEXO include Aurora Cannabis (ACB) , Amryt Pharma (AMYT) , HLS Therapeutics (HLS) , OrganiGram (OGI) , Benc...
What other stocks do shareholders of HEXO own?
Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB) , Aurora...
What is HEXO's stock symbol?
HEXO trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HEXO."
How do I buy shares of HEXO?
Shares of HEXO and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
About HEXO
Headlines
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name.
HEXO (TSE:HEXO) Frequently Asked Questions
Russia Proposes Crypto Crackdown. Bitcoin’s Reaction? No Problem - Yahoo Canada Finance
Cash needed!
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HEXO stock.
Should you buy?
During the latest earnings report, HEXO stock reported total net sales were down 2% year over year. Yet the company continues to be the number one choice for cannabis beverages, so that’s something, though sales were down $10.2 million.
Stock Advisor Canada Returns
Now comes the real question. HEXO stock has set itself up with some strong acquisitions to take advantage of U.S. legalization when it happens. And it will happen eventually. But whether HEXO stock will be around to see it is the question. The company has stretched itself incredibly thin, at levels it may not be able to come back from.
The stock is basically a wild card right now
Returns since inception, October 2013. Current as of February 23, 2022.
What went wrong?
Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Lately expanding into innovations in cryptocurrency alongside biotech/cannabis content. Fool since April 2020.
Is now the time to buy?
HEXO's revenue grew by just 2% year over year in Q3 2021 to $22.6 million Canadian dollars. Meanwhile, its loss from operations decreased slightly from CA$21.1 million to CA$16.1 million during the same period. The results were disappointing in the context of the 94% year-over-year revenue growth HEXO achieved in the second quarter.
The Analyst
The good news is that Quebec has begun lifting its restrictions as massive vaccination programs are in full steam. As a result, HEXO's sales will likely return to growth as early as this quarter. The company also has a lot of upcoming mergers and acquisitions.
A Stock Plunge
Cantor Fitzgerald's analyst Pablo Zuanic lowered the price on HEXO shares to CA$2.29 ($1.85) from CA$3.45, maintaining a neutral rating after projecting that the company will miss sales estimates for the quarter by 15%.
